Anyone venturing into digital pan-European campaigns is still something of a pioneer, and it can be hugely rewarding for brand owners and agencies alike
07/02/2012
FEATURE
Pharma needs to identify and understand how individual HTA agencies are connected, viewing them as a network
06/02/2012
FEATURE
Deal watch: A look at the biggest mergers and acquisitions from 2011, including Sanofi's purchase of Genzyme and J&J taking over Synthes
03/02/2012
FEATURE
The key to true market access success begins with corporate ownership…
02/02/2012
FEATURE
Industry needs to be perceived as a contributor to healthcare solutions not just a cost
01/02/2012
FEATURE
Embedding and integrating market access strategies company-wide is key
31/01/2012
FEATURE
Modern market access activities need to be evidence-based. But what does this really mean for new products being taken to market around the world?
30/01/2012
FEATURE
Currently facing a major financial crisis, Spain's healthcare system is overstretched with autonomous regions owing millions of Euros to suppliers such as the pharma industry
27/01/2012
FEATURE
Therapies are facing greater scrutiny to ensure they do not carry increased risk of cardiovascular side effects
27/01/2012
FEATURE
How centrally developed advertising campaigns can work in local markets and taking tips from motor industry campaigns can help increase brand engagement
25/01/2012
FEATURE
A survey of pharma companies shows they are hiring expert help to cope with the problems of an increasingly fragmented market in the UK
24/01/2012
FEATURE
Patients seldom refuse therapy outright, but often show a reluctance to comply. Understanding the reasons for this is the first step to improving their treatment
23/01/2012
FEATURE
When Apple's Steve Jobs unveiled the iPad in early 2010, he probably did not anticipate that the tablet would challenge the business laptop market so quickly
20/01/2012
FEATURE
This month in pharma: January 1964, and the publication of the US Surgeon General's 'Smoking and Health' report
19/01/2012
FEATURE
The new regulation has caught many in the industry off guard and the European Medicines Agency has given companies just months to respond to this mandate, one of the most expansive regulatory reforms in decades
17/01/2012
FEATURE
GE Healthcare's president and CEO tells Dominic Tyer about the rising importance of molecular diagnostics and how his company is moving increasingly closer to the biopharmaceutical world
16/01/2012
FEATURE
Use best practices to create a cohesive strategy for a successful product launch, whether it is for a small molecule, biologic, vaccine or device
13/01/2012
FEATURE
It is important to improve the risk-adjusted return on investment ratio when performing the annual brand plan review
12/01/2012
FEATURE
Though an attractive market potentially, this country has a slow registration procedure and an emphasis on drug cost rather than value
11/01/2012
FEATURE
Pharmaceutical public relations fulfils a much more important role than just creating promotional adverts; it is a vital adjunct in educating patients about drugs and diseases
10/01/2012
FEATURE